RESUMO
O procedimento de imunocastração vem sendo utilizado como técnica alternativa amplamente favorável ao bem-estar animal, por ser indolor, pouco invasiva e com eficácia semelhante à da castração cirúrgica, que causa maior estresse aos animais, principalmente quando realizada de forma inadequada. A imunocastração estimula a produção de anticorpos contra o Hormônio Liberador de Gonadotrofina (GnRH), bloqueando temporariamente a produção da testosterona pelas gônadas masculinas. Face a escassez de informações sobre este procedimento em touros bubalinos, o estudo teve como objetivo analisar os possíveis efeitos da imunocastração no parênquima testicular de búfalos. Vinte touros bubalinos, com idade entre 2 a 3 anos, oriundos da ilha do Marajó PA, foram avaliados e divididos aleatoriamente em dois grupos composto por dez animais no grupo controle (GC) e dez do grupo imunocastrado (GIM). O produto utilizado foi a vacina anti-GnRH Bopriva ® (Zoetis, SP, Brasil). O GIM recebeu duas doses de 1,0ml contendo 400µg da vacina Bopriva ® com intervalo de 8 semanas entre as aplicações e o grupo controle recebeu 1,0 ml de solução fisiológica. Após 14 dias da última dose, os animais foram abatidos e coletado os 20 pares de testículos para analises de parâmetros macroscópicos como: comprimento, largura, circunferência e peso. Além disso, foi realizada a retirada de fragmentos do parênquima testicular para confecção de lâminas histológicas. Para comparação dos dados foi aplicado o teste t de Student (Nonparametric Test) considerando a significância com p<0,05 e intervalo de confiança de 95%. Foi observado diferença significativa entre os dois grupos para grupos para peso (direto p<0001; esquerdo p≤ 0,0001), circunferência (direita p< <0,0001), 1; esquerda p<0,0001), ), largura (somente lado direito p<0,0372) e comprimento (direita p≤ 0,0013; esquerda p<0,0437). Na avaliação microscópica, os animais do GC não apresenteram alterações. Nos animais do GIM houve degeneração em todas as amostras, sendo visualizado descamação, tortuosidade e espessamento da membrana basal do túbulo seminífero, assim como vacuolização e atrofia das células de Sertoli. Foi observado também uma redução do número de células de Leydig, fibrose intertubular pronunciada, núcleos picnóticos, azoospermia e células multinucleadas no interior dos túbulos. Conclui-se a vacina anti-GnRH mostrou-se eficaz em provocar lesões no parênquima testicular, comprometendo significativamente a espermatogênese a partir da possível supressão de testosterona.(AU)
The immunocastration procedure has been used as an alternative technique widely favorable to animal welfare, as it is painless, minimally invasive and with similar efficacy to surgical castration, which causes greater stress to animals, especially when performed improperly. Immunocastration stimulates the production of antibodies against Gonadotropin Releasing Hormone (GnRH), temporarily blocking the production of testosterone by the male gonads. Due to the scarcity of information about this procedure in buffalo bulls, the study aimed to analyze the possible effects of immunocastration on the testicular parenchyma of buffaloes. Twenty buffalo bulls, aged between 2 and 3 years, from the island of Marajó - PA, were evaluated and randomly divided into two groups consisting of ten animals in the control group (CG) and ten from the immunocastrated group (GIM). The product used was the anti-GnRH vaccine Bopriva ® (Zoetis, SP, Brazil). The GIM received two doses of 1.0ml containing 400µg of Bopriva ® vaccine with an interval of 8 weeks between applications and the control group received 1.0 ml of saline solution. After 14 days of the last dose, the animals were slaughtered and the 20 pairs of testes were collected for analysis of macroscopic parameters such as: length, width, circumference and weight. In addition, fragments of the testicular parenchyma were removed for the preparation of histological slides. To compare the data, Student's t test (Nonparametric Test) was applied, considering the significance with p< 0.0372) and length (right p≤ 0.0013; left p<0.0437). In the microscopic evaluation, the animals of the CG showed no alterations. In the GIM animals there was degeneration in all samples, with desquamation, tortuosity and thickening of the seminiferous tubule basement membrane, as well as vacuolization and atrophy of Sertoli cells. A reduction in the number of Leydig cells, pronounced intertubular fibrosis, pyknotic nuclei, azoospermia and multinucleated cells within the tubules were also observed. In conclusion, the anti-GnRH vaccine proved to be effective in causing lesions in the testicular parenchyma, significantly compromising spermatogenesis from the possible suppression of testosterone.(AU)
Assuntos
Animais , Masculino , Búfalos/fisiologia , Castração/veterinária , Receptores LHRH/imunologia , Epitélio Seminífero/imunologia , Bem-Estar do AnimalRESUMO
The aim of this study was to compare testicle morpho-functional characteristics in bulls undergoing a single or two immunizations against GnRH. Nelore (Bos taurus indicus) bulls were randomly allocated into three experimental groups: G1 (n=12), a single 400 µg dose of anti-GnRH vaccine on day 0; G2 (n=11), a first 400 µg dose of anti-GnRH vaccine on day 0 followed by a second (boost) dose 30 days later; and control group (CG, n=12), 1 mL saline 0.9% at day 0. Every 30 days, from day 0 until slaughter at day 90, the bulls were weighed and underwent testicular biometry, semen collection and analysis, and blood sample collection for testosterone measurement. Immediately after slaughter, the testicles were removed and transport at 15°C to the laboratory for histopathological analysis. There was a decrease in testicular height (P=0.0476), width (P=0.0021), and in scrotal circumference (P=0.0001), after either a single (G1) or two (G2) immunizations against GnRH. Both G1 and G2 had lower testosterone concentrations than CG from day 60 on (P<0.01), but in G2, it was also lower than in G1 at day 90 (P=0.0006). All sperm parameters were affected by active immunization against GnRH (P<0.05), and in G2, averages were lesser (P<0.05) than in G1 from day 60 on. No signs of seminiferous tubule degeneration were found in any sample from the CG, contrasting with 75.0% and 100.0% of the samples from G1 and G2, respectively. In summary, immunocastration affected testicle morpho-functional characteristics in bulls in a time- and dose-dependent way.
Assuntos
Testículo , Vacinas , Animais , Bovinos , Hormônio Liberador de Gonadotropina , Masculino , Escroto , Espermatozoides , TestosteronaRESUMO
Background: Immunocastration is a less invasive and painless procedure compared to surgical castration, which causesgreater stress to animals, especially when performed improperly. Immunocastration stimulates the production of antibodiesagainst Gonadotropin-Releasing Hormone (GnRH), temporarily blocking the hormone production by the male gonads.Anatomopathological evaluation of animals submitted to immunocastration with the establishment of different degrees oftesticular degeneration helps to evaluate the efficacy of the different dose ranges used for this procedure. Because of thescarcity of information about this procedure in young bulls, the study aimed to compare the immunocastrated and noncastrated animals.Materials, Methods & Results: Eighteen Angus-Limousin bulls were used from weaning (7±1 months) to slaughtering(15±1 months) with the establishment of two groups composed of nine non-castrated (NC) and nine immunocastrated (IC)animals. In the IC group, three doses of GnRH synthesis inhibitor vaccine (Bopriva®) were applied on days 0 (weaning),87 and 223. At slaughter, scrotal circumference, weight (kg), width (cm), length (cm) and total size (width x length) of thetesticles were obtained, then were routinely processed for histopathological analysis. Four degrees of testicular degeneration was established: grade 0 (no changes), grade 1 (mild), grade 2 (moderate) and grade 3 (severe). Statistical analysiswas performed using Students t-test to compare the means of macroscopic variables. The scrotal circumference startedto decrease in the IC animals on day 132, with a certain growth from day 194. There was a significant difference betweenthe two groups for width (P = 0.001), length (P = 0.004), total size (P = 0.003) and scrotal circumference (P = 0.04).Testicles of the IC group tended to be lighter (P = 0.06)...(AU)
Assuntos
Animais , Masculino , Bovinos , Testículo/anatomia & histologia , Testículo/efeitos dos fármacos , Hormônio Liberador de Gonadotropina/antagonistas & inibidoresRESUMO
Background: Immunocastration is a less invasive and painless procedure compared to surgical castration, which causesgreater stress to animals, especially when performed improperly. Immunocastration stimulates the production of antibodiesagainst Gonadotropin-Releasing Hormone (GnRH), temporarily blocking the hormone production by the male gonads.Anatomopathological evaluation of animals submitted to immunocastration with the establishment of different degrees oftesticular degeneration helps to evaluate the efficacy of the different dose ranges used for this procedure. Because of thescarcity of information about this procedure in young bulls, the study aimed to compare the immunocastrated and noncastrated animals.Materials, Methods & Results: Eighteen Angus-Limousin bulls were used from weaning (7±1 months) to slaughtering(15±1 months) with the establishment of two groups composed of nine non-castrated (NC) and nine immunocastrated (IC)animals. In the IC group, three doses of GnRH synthesis inhibitor vaccine (Bopriva®) were applied on days 0 (weaning),87 and 223. At slaughter, scrotal circumference, weight (kg), width (cm), length (cm) and total size (width x length) of thetesticles were obtained, then were routinely processed for histopathological analysis. Four degrees of testicular degeneration was established: grade 0 (no changes), grade 1 (mild), grade 2 (moderate) and grade 3 (severe). Statistical analysiswas performed using Students t-test to compare the means of macroscopic variables. The scrotal circumference startedto decrease in the IC animals on day 132, with a certain growth from day 194. There was a significant difference betweenthe two groups for width (P = 0.001), length (P = 0.004), total size (P = 0.003) and scrotal circumference (P = 0.04).Testicles of the IC group tended to be lighter (P = 0.06)...
Assuntos
Masculino , Animais , Bovinos , Hormônio Liberador de Gonadotropina/antagonistas & inibidores , Testículo/anatomia & histologia , Testículo/efeitos dos fármacosRESUMO
Bopriva® exerts anti-gonadotropin-releasing hormone (GnRH) activity and is used for immunocastration of cattle. The objective of this study was to evaluate the effect of Bopriva® on scrotal circumference and sperm production and quality of Nellore bulls. Five Nellore bulls (Bos taurus indicus), aged 12 months, received two doses of Bopriva® at an interval of 30 days, with each dose of 1 mL/animal containing 400 μg of the product. At 2-weeks intervals, scrotal circumference was measured and semen was collected by electroejaculation (seven samplings) and submitted to physical and morphological analysis. Scrotal circumference significantly decreased after the 4th sampling (P=0.0056) and sperm motility ranged from 20% to 66% (mean of 39%), sperm vigor from 1.0 to 2.8 (mean of 1.74), and sperm concentration from 87.8 to 296.2 million spermatozoa per mL (mean of 242.9 million). The percentage of total sperm defects ranged from 36% to 75.6% (mean of 49.51%), with a high incidence of cytoplasmic droplets, bent tails and detached heads. Bopriva® reduces scrotal circumference and interferes with semen quality in Nellore animals, reducing sperm motility and increasing the percentage of sperm abnormalities in the ejaculate.
O medicamento Bopriva® tem ação anti-GnRH (GnRH - hormônio liberador das gonadotrofinas) e é utilizado na imunocastração de bovinos. Este estudo teve por objetivo avaliar o efeito do medicamento Bopriva® no perímetro escrotal e na produção e qualidade dos espermatozoides de touros de raça Nelore. Foram utilizados cinco animais da raça Nelore (Bos taurus indicus), com12 meses de idade, que receberam duas doses de Bopriva® com intervalo de 30 dias, sendo cada dose de 1 mL/animal com 400 μg do produto. Foram realizadas, quinzenalmente, a medida do perímetro escrotal e coleta de sêmen pelo método de eletroejaculação (sete coletas), sendo o sêmen analisado física e morfologicamente. O perímetro escrotal reduziu a partir da 4ª coleta de forma significativa (P=0,0056), a motilidade espermática variou de 20% a 66% (média de 39%), o vigor de 1,0 a 2,8 (média de 1,74), a concentração de 87,8 a 296,2 milhões deespermatozóide por mL (média de 242,9 milhões) e os defeitos totais de 36% a 75,6% (média de 49,51%) com alta incidência de gotas citoplasmáticas, caudas enroladas e cabeças isoladas. Omedicamento Bopriva®causa redução do perímetro escrotal e interfere na qualidade do sêmen dos animais da raça Nelore, reduzindo a motilidade do sêmen e elevando a porcentagem de anormalidades espermáticas totais do ejaculado.
Assuntos
Masculino , Animais , Bovinos , Capacitação Espermática/fisiologia , Capacitação Espermática/imunologia , Orquiectomia/efeitos adversos , Orquiectomia/veterinária , Bovinos/anatomia & histologia , Bovinos/fisiologiaRESUMO
Bopriva® exerts anti-gonadotropin-releasing hormone (GnRH) activity and is used for immunocastration of cattle. The objective of this study was to evaluate the effect of Bopriva® on scrotal circumference and sperm production and quality of Nellore bulls. Five Nellore bulls (Bos taurus indicus), aged 12 months, received two doses of Bopriva® at an interval of 30 days, with each dose of 1 mL/animal containing 400 μg of the product. At 2-weeks intervals, scrotal circumference was measured and semen was collected by electroejaculation (seven samplings) and submitted to physical and morphological analysis. Scrotal circumference significantly decreased after the 4th sampling (P=0.0056) and sperm motility ranged from 20% to 66% (mean of 39%), sperm vigor from 1.0 to 2.8 (mean of 1.74), and sperm concentration from 87.8 to 296.2 million spermatozoa per mL (mean of 242.9 million). The percentage of total sperm defects ranged from 36% to 75.6% (mean of 49.51%), with a high incidence of cytoplasmic droplets, bent tails and detached heads. Bopriva® reduces scrotal circumference and interferes with semen quality in Nellore animals, reducing sperm motility and increasing the percentage of sperm abnormalities in the ejaculate.(AU)
O medicamento Bopriva® tem ação anti-GnRH (GnRH - hormônio liberador das gonadotrofinas) e é utilizado na imunocastração de bovinos. Este estudo teve por objetivo avaliar o efeito do medicamento Bopriva® no perímetro escrotal e na produção e qualidade dos espermatozoides de touros de raça Nelore. Foram utilizados cinco animais da raça Nelore (Bos taurus indicus), com12 meses de idade, que receberam duas doses de Bopriva® com intervalo de 30 dias, sendo cada dose de 1 mL/animal com 400 μg do produto. Foram realizadas, quinzenalmente, a medida do perímetro escrotal e coleta de sêmen pelo método de eletroejaculação (sete coletas), sendo o sêmen analisado física e morfologicamente. O perímetro escrotal reduziu a partir da 4ª coleta de forma significativa (P=0,0056), a motilidade espermática variou de 20% a 66% (média de 39%), o vigor de 1,0 a 2,8 (média de 1,74), a concentração de 87,8 a 296,2 milhões deespermatozóide por mL (média de 242,9 milhões) e os defeitos totais de 36% a 75,6% (média de 49,51%) com alta incidência de gotas citoplasmáticas, caudas enroladas e cabeças isoladas. Omedicamento Bopriva®causa redução do perímetro escrotal e interfere na qualidade do sêmen dos animais da raça Nelore, reduzindo a motilidade do sêmen e elevando a porcentagem de anormalidades espermáticas totais do ejaculado.(AU)